These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30801786)

  • 1. Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series.
    Gisondi P; Mattiucci A; Tonin B; Girolomoni G
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):e246-e247. PubMed ID: 30801786
    [No Abstract]   [Full Text] [Related]  

  • 2. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
    Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
    Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional therapies for psoriasis.
    Rebora A
    Reumatismo; 2007; 59 Suppl 1():77-80. PubMed ID: 17828351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verrucous psoriasis treated with methotrexate and acitretin combination therapy.
    Shivers L; Montanez-Wiscovich ME
    Cutis; 2019 Dec; 104(6):E10-E12. PubMed ID: 31939936
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
    Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
    Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
    Short MW; Vaughan TK
    Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Psoriasis Therapies.
    James J; Otto T; Gao J; Porter ML
    Dermatol Clin; 2024 Jul; 42(3):357-363. PubMed ID: 38796267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psoriasis].
    Guilhou JJ; Girard C
    Rev Prat; 2006 Dec; 56(19):2153-8. PubMed ID: 17416055
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate versus Acitretin in the Treatment of Chronic Hand Dermatitis.
    O'Shea PM; Lugo-Somolinos A
    J Drugs Dermatol; 2015 Dec; 14(12):1389-91. PubMed ID: 26659930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate.
    Stanford CW; Kollipara R; Melookaran AM; Hall JC
    Cutis; 2014 Sep; 94(3):153-5. PubMed ID: 25279477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent use of methotrexate and acitretin revisited.
    Lowenthal KE; Horn PJ; Kalb RE
    J Dermatolog Treat; 2008; 19(1):22-6. PubMed ID: 18273721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
    Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A
    J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acitretin for the treatment of psoriasis: an assessment of national trends.
    Ghasri P; Yentzer BA; Dabade TS; Feldman SR
    J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance in psoriasis treatment.
    Kumar B; Saraswat A
    J Am Acad Dermatol; 2001 Jul; 45(1):153-4. PubMed ID: 11423858
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood psoriasis: often favorable outcome.
    Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs.
    Tabolli S; Giannantoni P; Paradisi A; Abeni D
    Br J Dermatol; 2015 Jul; 173(1):256-8. PubMed ID: 25422080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.